DexCom Statistics

Total Valuation

DexCom has a market cap or net worth of EUR 23.99 billion. The enterprise value is 24.00 billion.

Market Cap	23.99B
Enterprise Value	24.00B

Important Dates

The next estimated earnings date is Thursday, May 1, 2025.

Earnings Date	May 1, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-3.01%
Shares Change (QoQ)	-0.85%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	387.93M

Valuation Ratios

The trailing PE ratio is 43.10.

PE Ratio	43.10
Forward PE	n/a
PS Ratio	6.16
PB Ratio	11.81
P/TBV Ratio	12.57
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 31.84, with an EV/FCF ratio of 39.40.

EV / Earnings	43.13
EV / Sales	6.73
EV / EBITDA	31.84
EV / EBIT	45.27
EV / FCF	39.40

Financial Position

The company has a current ratio of 1.47, with a Debt / Equity ratio of 1.23.

Current Ratio	1.47
Quick Ratio	1.23
Debt / Equity	1.23
Debt / EBITDA	3.04
Debt / FCF	4.11
Interest Coverage	31.58

Financial Efficiency

Return on equity (ROE) is 27.63% and return on invested capital (ROIC) is 8.01%.

Return on Equity (ROE)	27.63%
Return on Assets (ROA)	5.88%
Return on Invested Capital (ROIC)	8.01%
Return on Capital Employed (ROCE)	16.89%
Revenue Per Employee	380,046
Profits Per Employee	54,298
Employee Count	10,300
Asset Turnover	0.63
Inventory Turnover	2.79

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -55.27% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-55.27%
50-Day Moving Average	72.25
200-Day Moving Average	72.87
Relative Strength Index (RSI)	41.87
Average Volume (20 Days)	122

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.58

Income Statement

In the last 12 months, DexCom had revenue of EUR 3.90 billion and earned 556.55 million in profits. Earnings per share was 1.38.

Revenue	3.90B
Gross Profit	2.36B
Operating Income	579.54M
Pretax Income	684.82M
Net Income	556.55M
EBITDA	789.82M
EBIT	579.54M
Earnings Per Share (EPS)	1.38

Full Income Statement

Balance Sheet

The company has 2.49 billion in cash and 2.51 billion in debt, giving a net cash position of -13.91 million.

Cash & Cash Equivalents	2.49B
Total Debt	2.51B
Net Cash	-13.91M
Net Cash Per Share	n/a
Equity (Book Value)	2.03B
Book Value Per Share	5.20
Working Capital	1.32B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 955.76 million and capital expenditures -346.56 million, giving a free cash flow of 609.19 million.

Operating Cash Flow	955.76M
Capital Expenditures	-346.56M
Free Cash Flow	609.19M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 60.46%, with operating and profit margins of 14.88% and 14.29%.

Gross Margin	60.46%
Operating Margin	14.88%
Pretax Margin	17.58%
Profit Margin	14.29%
EBITDA Margin	20.28%
EBIT Margin	14.88%
FCF Margin	15.64%

Dividends & Yields

DexCom does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	3.01%
Shareholder Yield	3.01%
Earnings Yield	2.32%
FCF Yield	2.54%

Stock Splits

The last stock split was on June 13, 2022. It was a forward split with a ratio of 4.

Last Split Date	Jun 13, 2022
Split Type	Forward
Split Ratio	4

Scores

DexCom has an Altman Z-Score of 6.99.

Altman Z-Score	6.99
Piotroski F-Score	n/a